AxoGen, Inc. (AXGN) vs Azenta, Inc. (AZTA)
A side-by-side comparison of AxoGen, Inc. and Azenta, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
AXGN
AxoGen, Inc.
$37.22HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
AZTA
Azenta, Inc.
$42.73HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — AXGN vs AZTA
growth of $100 · dividends reinvested · last 10yAXGN +326.8% (+15.6%/yr)AZTA +237.6% (+12.9%/yr)AXGN compounded faster over this window
AXGN AZTA
AXGN vs AZTA: by the numbers
- •AXGN is the larger company ($2.00B vs $1.97B market cap).
- •Both run net losses; AXGN's is the smaller (-13.36% vs -20.02% net margin).
- •AXGN grew revenue faster over the past five years (13.99% vs 4.82% CAGR).
Metrics side by side
Valuation
| Metric | AXGN | AZTA |
|---|---|---|
| Forward P/E | 84.11 | 86.03 |
| P/S ratio | 7.97 | 3.21 |
| P/B ratio | 7.81 | 1.30 |
| EV / EBITDA | N/A | 53.56 |
| FCF yield | 0.13% | 0.50% |
Profitability
| Metric | AXGN | AZTA |
|---|---|---|
| Gross margin | 74.56% | 44.05% |
| Operating margin | -5.12% | -3.49% |
| Net margin | -13.36% | -20.02% |
| ROE | -13.09% | -8.14% |
| ROIC | -4.68% | -1.33% |
Growth (annualized)
| Metric | AXGN | AZTA |
|---|---|---|
| Revenue CAGR (5Y) | 13.99% | 4.82% |
| Total return CAGR (5Y) | 19.40% | -15.91% |
Frequently asked
- Which has grown faster, AXGN or AZTA?
- Over the past five years, AXGN grew revenue faster — AXGN at a 13.99% CAGR versus AZTA at 4.82%.
- How have AXGN and AZTA total returns compared?
- Over the past 10 years, AXGN delivered 15.98% and AZTA delivered 12.81% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
AxoGen ROEAzenta ROEAxoGen operating marginAzenta operating marginAxoGen revenue growthAzenta revenue growthAxoGen free cash flowAzenta free cash flow
AxoGen & Azenta appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.